4
Changes in Ownership
Indaptus Therapeutics, Inc. Filed Acc 0001493152-22-003002
CSO and Director sold 20,000 shares at an average $5.00 ($100,043)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Newman Michael James CSO and Director | 2022-01-31 | Sale | −5,870 | $5.00 | $29,351 | 1,382,486 | I |
| Newman Michael James CSO and Director | 2022-02-01 | Sale | −14,130 | $5.00 | $70,692 | 1,368,356 | I |
| Open-market sales · 20,000 sh · avg $5.00 · $100,043 | |||||||
Loading xslF345X03/ownership.xml…